Calcium channels and their blockers in intraocular pressure and glaucoma

European Journal of Pharmacology

Volumn 739, Issue C, 2014, Pages 96-105

  Mayama, Chihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Blood flow; Calcium channel blocker; Glaucoma; Intraocular pressure; Neuroprotection; Visual field

Indexed keywords

ANTIGLAUCOMA AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; FLUNARIZINE; IGANIDIPINE; LOMERIZINE; NICARDIPINE; NIFEDIPINE; NILVADIPINE; NIMODIPINE; PRANIDIPINE; VERAPAMIL;

BLOOD BRAIN BARRIER; BLOOD RETINA BARRIER; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; GLAUCOMA; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA GANGLION CELL; REVIEW; TREATMENT DURATION; VASODILATATION; VISUAL ACUITY; VISUAL SYSTEM FUNCTION; ANIMAL; BLOOD FLOW; DRUG EFFECTS; METABOLISM; NERVOUS SYSTEM; PATHOPHYSIOLOGY;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; NERVOUS SYSTEM; REGIONAL BLOOD FLOW;

EID: 84925032413     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.073     Document Type: Review

References (187)

1. M.B. Abelson, C.M. Gilbert, and L.M. Smith Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil Am. J. Ophthalmol. 105 1988 155 159
2. D.R. Abernethy, and J.B. Schwartz Calcium-antagonist drugs N. Engl. J. Med. 341 1999 1447 1457
3. D.R. Abernethy, and J.B. Schwartz Calcium-antagonist drugs N. Engl. J. Med. 341 1999 1447 1457
4. M.M. Abreu, Y.Y. Kim, D.H. Shin, and P.A. Netland Topical verapamil and episcleral venous pressure Ophthalmology 105 1998 2251 2255
5. G.S. Allen, H.S. Ahn, T.J. Preziosi, R. Battye, S.C. Boone, S.N. Chou, D.L. Kelly, B.K. Weir, R.A. Crabbe, P.J. Lavik, S.B. Rosenbloom, F.C. Dorsey, C.R. Ingram, D.E. Mellits, L.A. Bertsch, D.P. Boisvert, M.B. Hundley, R.K. Johnson, J.A. Strom, and C.R. Transou Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage N. Engl. J. Med. 308 1983 619 624
6. M. Araie, J. Crowston, A. Iwase, A. Tomidokoro, C. Leung, O. Zeitz, A. Vingris, L. Schmetterer, R. Ritch, M. Kook, R. Ehrlich, D. Gherghel, S. Graham, and A. Harris Clinical Relevance of Ocular Blood Flow (OBF) Measurements Including Effects of General Medications or Specific Glaucoma Treatment 2009 Kugler Publications Amsterdam
7. D.C. Baptiste, A.T. Hartwick, C.A. Jollimore, W.H. Baldridge, B.C. Chauhan, F. Tremblay, and M.E. Kelly Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina Invest. Ophthalmol. Vis. Sci. 43 2002 2666 2676
8. J.F. Beatty, T. Krupin, P.F. Nichols, and B. Becker Elevation of intraocular pressure by calcium channel blockers Arch. Ophthalmol. 102 1984 1072 1076
9. H. Bessho, J. Suzuki, and A. Tobe Vascular effects of betaxolol, a cardioselective beta-adrenoceptor antagonist, in isolated rat arteries Jpn. J. Pharmacol. 55 1991 351 358
10. G. Besson, and J. Bogousslavsky Medical treatment of acute ischemic stroke J. Cardiovasc. Pharmacol. 18 Suppl 8 1991 S6 9
11. A. Bill, and G.O. Sperber Control of retinal and choroidal blood flow Eye (London) 4 Pt 2 1990 319 325
12. K. Blomgren, C. Zhu, X. Wang, J.O. Karlsson, A.L. Leverin, B.A. Bahr, C. Mallard, and H. Hagberg Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J. Biol. Chem. 276 2001 10191 10198
13. A.G. Boehm, K.A. Breidenbach, L.E. Pillunat, A.S. Bernd, M.F. Mueller, and A.U. Koeller Visual function and perfusion of the optic nerve head after application of centrally acting calcium-channel blockers Graefe's Arch. Clin. Exp. Ophthalmol. (Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie) 241 2003 34 38
14. L. Bonomi, G. Marchini, M. Marraffa, P. Bernardi, R. Morbio, and A. Varotto Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study Ophthalmology 107 2000 1287 1293
15. S. Bose, J.R. Piltz, and M.E. Breton Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects Ophthalmology 102 1995 1236 1241
16. E. Braunwald Mechanism of action of calcium-channel-blocking agents N. Engl. J. Med. 307 1982 1618 1627
17. G. Campana, C. Bucolo, G. Murari, and S. Spampinato Ocular hypotensive action of topical flunarizine in the rabbit: role of sigma 1 recognition sites J. Pharmacol. Exp. Ther. 303 2002 1086 1094
18. M. Cellini, P. Versura, E. Zamparini, E. Bendo, and E.C. Campos Effects of endothelin-1 and flunarizine on human trabecular meshwork cell contraction Exp. Biol. Med. (Maywood) 231 2006 1081 1084
19. H.S. Chen, J.W. Pellegrini, S.K. Aggarwal, S.Z. Lei, S. Warach, F.E. Jensen, and S.A. Lipton Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity J. Neurosci. 12 1992 4427 4436
20. Y.N. Chen, H. Yamada, W. Mao, S. Matsuyama, M. Aihara, and M. Araie Hypoxia-induced retinal ganglion cell death and the neuroprotective effects of beta-adrenergic antagonists Brain Res. 1148 2007 28 37
21. Y.D. Cheng, L. Al-Khoury, and J.A. Zivin Neuroprotection for ischemic stroke: two decades of success and failure NeuroRx. 1 2004 36 45
22. E.W. Cheon, C.H. Park, Y.S. Kim, C.H. Cho, Y.C. Chung, J.G. Kwon, J.M. Yoo, W.S. Choi, and G.J. Cho Protective effects of betaxolol in eyes with kainic acid-induced neuronal death Brain Res. 1069 2006 75 85
23. D.W. Choi Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage Trends Neurosci. 11 1988 465 469
24. D.W. Choi Calcium: still center-stage in hypoxic-ischemic neuronal death Trends Neurosci. 18 1995 58 60
25. M. Ciancaglini, P. Carpineto, C. Costagliola, and L. Matropasqua Perfusion of the optic nerve head and visual field damage in glaucomatous patients Graefes Arch. Clin. Exp. Ophthalmol. 239 2001 549 555
26. J.N. Cohn Calcium, vascular smooth muscle, and calcium entry blockers in hypertension Ann. Intern. Med. 98 1983 806 809
27. Collaborative Normal-Tension Glaucoma Study Group Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures Am. J. Ophthalmol. 126 1998 487 497
28. Collaborative Normal-Tension Glaucoma Study Group The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma Am. J. Ophthalmol. 126 1998 498 505
29. C.E. Crosson, J.A. Willis, and D.E. Potter Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction J. Ocul. Pharmacol. 6 1990 293 299
30. A. Das, D.P. Garner, A.M. Del Re, J.J. Woodward, D.M. Kumar, N. Agarwal, N.L. Banik, and S.K. Ray Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx Brain Res. 1084 2006 146 157
31. L. Daugeliene, T. Yamamoto, and Y. Kitazawa Risk factors for visual field damage progression in normal-tension glaucoma eyes Graefes Arch. Clin. Exp. Ophthalmol. 237 1999 105 108
32. U. Dirnagl, M. Jacewicz, and W. Pulsinelli Nimodipine posttreatment does not increase blood flow in rats with focal cortical ischemia Stroke 21 1990 1357 1361
33. Y. Dong, H. Ishikawa, Y. Wu, K. Shimizu, T. Goseki, and T. Yoshitomi Effect and mechanism of betaxolol and timolol on vascular relaxation in isolated rabbit ciliary artery Jpn. J. Ophthalmol. 50 2006 504 508
34. Y. Dong, H. Ishikawa, Y. Wu, and T. Yoshitomi Vasodilatory mechanism of levobunolol on vascular smooth muscle cells Exp. Eye Res. 84 2007 1039 1046
35. S. Drance, D.R. Anderson, and M. Schulzer Risk factors for progression of visual field abnormalities in normal-tension glaucoma Am. J. Ophthalmol. 131 2001 699 708
36. K.A. Erickson, A. Schroeder, and P.A. Netland Verapamil increases outflow facility in the human eye Exp. Eye Res. 61 1995 565 567
37. D.W. Evans, A. Harris, M. Garrett, H.S. Chung, and L. Kagemann Glaucoma patients demonstrate faulty autoregulation of ocular blood flow during posture change Br. J. Ophthalmol. 83 1999 809 813
38. M. Fitzgerald, S.C. Payne, C.A. Bartlett, L. Evill, A.R. Harvey, and S.A. Dunlop Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine Invest. Ophthalmol. Vis. Sci. 50 2009 5456 5462
39. C.L. Franke, R. Palm, M. Dalby, H.C. Schoonderwaldt, L. Hantson, B. Eriksson, L. Lang-Jenssen, and J. Smakman Flunarizine in stroke treatment (FIST): a double-blind, placebo-controlled trial in Scandinavia and the Netherlands Acta Neurol. Scand. 93 1996 56 60
40. M. Frasson, J.A. Sahel, M. Fabre, M. Simonutti, H. Dreyfus, and S. Picaud Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse Nat. Med. 5 1999 1183 1187
41. F. Galassi, A. Sodi, F. Ucci, G. Renieri, B. Pieri, and M. Baccini Ocular hemodynamics and glaucoma prognosis: a color Doppler imaging study Arch. Ophthalmol. 121 2003 1711 1715
42. P. Gasser, and J. Flammer Influence of vasospasm on visual function Doc. Ophthalmol. 66 1987 3 18
43. P. Gasser, and J. Flammer Short- and long-term effect of nifedipine on the visual field in patients with presumed vasospasm J. Int. Med. Res. 18 1990 334 339
44. O. Geyer, M. Neudorfer, A. Kessler, E. Firsteter, M. Lazar, and Y. Almog Effect of oral nifedipine on ocular blood flow in patients with low tension glaucoma Br. J. Ophthalmol. 80 1996 1060 1062
45. D. Gherghel, S. Orgul, K. Gugleta, and J. Flammer Retrobulbar blood flow in glaucoma patients with nocturnal over-dipping in systemic blood pressure Am. J. Ophthalmol. 132 2001 641 647
46. M.V. Gibbens The consensual ophthalmotonic reaction Br. J. Ophthalmol. 72 1988 746 749
47. W. Goto, T. Ota, N. Morikawa, Y. Otori, H. Hara, K. Kawazu, N. Miyawaki, and Y. Tano Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina Brain Res. 958 2002 10 19
48. O. Gotoh, A.A. Mohamed, J. McCulloch, D.I. Graham, A.M. Harper, and G.M. Teasdale Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat J. Cereb. Blood Flow Metab. 6 1986 321 331
49. J.K. Goyal, G. Khilnani, D.P. Sharma, and J. Singh The hypotensive effect of verapamil eye drops on ocular hypertension Indian J. Ophthalmol. 37 1989 176 178
50. K. Green, and K. Kim Papaverine and verapamil interaction with prostaglandin E2 and delta9-tetrahydrocannabinol in the eye Exp. Eye Res. 24 1977 207 212
51. U. Guthauser, J. Flammer, and F. Mahler The relationship between digital and ocular vasospasm Graefe's Arch. Clin. Exp. Ophthalmol. (Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie) 226 1988 224 226
52. Y. Hagiwara, T. Yamamoto, and Y. Kitazawa The effect of mitomycin C trabeculectomy on the progression of visual field defect in normal-tension glaucoma Graefes Arch. Clin. Exp. Ophthalmol. 238 2000 232 236
53. A.M. Hakim Cerebral acidosis in focal ischemia: II. Nimodipine and verapamil normalize cerebral pH following middle cerebral artery occlusion in the rat J. Cereb. Blood Flow Metab. 6 1986 676 683
54. H. Hara, T. Morita, T. Sukamoto, and F.M. Cutrer Lomerizine (KB-2796), a new antimigraine drug CNS Drug Rev. 1 1995 204 226
55. H. Hara, M. Shimazawa, M. Sasaoka, C. Yamada, Y. Iwakura, T. Sakai, Y. Maeda, T. Yamaguchi, T. Sukamoto, and M. Hashimoto Selective effects of lomerizine, a novel diphenylmethylpiperazine Ca2+ channel blocker, on cerebral blood flow in rats and dogs Clin. Exp. Pharmacol. Physiol. 26 1999 870 876
56. H. Hara, N. Toriu, and M. Shimazawa Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage Cardiovasc. Drug Rev. 22 2004 199 214
57. A. Harris, T.A. Ciulla, H.S. Chung, and B. Martin Regulation of retinal and optic nerve blood flow Arch. Ophthalmol. 116 1998 1491 1495
58. A. Harris, D.W. Evans, L.B. Cantor, and B. Martin Hemodynamic and visual function effects of oral nifedipine in patients with normal-tension glaucoma Am. J. Ophthalmol. 124 1997 296 302
59. A. Heijl, M.C. Leske, B. Bengtsson, L. Hyman, and M. Hussein Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial Arch. Ophthalmol. 120 2002 1268 1279
60. R.C. Herz, D.J. De Wildt, and D.H. Versteeg The effects of gamma 2-melanocyte-stimulating hormone and nimodipine on cortical blood flow and infarction volume in two rat models of middle cerebral artery occlusion Eur. J. Pharmacol. 306 1996 113 121
61. R.K. Hester, Z. Chen, E.J. Becker, M. McLaughlin, and L. DeSantis The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery Surv. Ophthalmol. 38 Suppl 1994 S125 134
62. K. Hirooka, M.E. Kelly, W.H. Baldridge, and S. Barnes Suppressive actions of betaxolol on ionic currents in retinal ganglion cells may explain its neuroprotective effects Exp. Eye Res. 70 2000 611 621
63. R.P. Hof Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem Br. J. Pharmacol. 78 1983 375 394
64. S.J. Hong, K.Y. Wu, H.Z. Wang, and J.C. Fong Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+]i increase in cultured neuroblastoma cells J. Ocul. Pharmacol. Ther. 19 2003 205 215
65. A.M. Hoste, P.J. Boels, L.J. Andries, D.L. Brutsaert, and J.J. De Laey Effects of beta-antagonists on contraction of bovine retinal microarteries in vitro Invest. Ophthalmol. Vis. Sci. 31 1990 1231 1237
66. A.M. Hoste, and S.U. Sys The relaxant action of betaxolol on isolated bovine retinal microarteries Curr. Eye Res. 13 1994 483 487
67. A.M. Hoste, and S.U. Sys Ca2+ channel-blocking activity of propranolol and betaxolol in isolated bovine retinal microartery J. Cardiovasc. Pharmacol. 32 1998 390 396
68. K. Ishida, T. Yamamoto, and Y. Kitazawa Clinical factors associated with progression of normal-tension glaucoma J. Glaucoma 7 1998 372 377
69. K. Ishii, Y. Fukaya, M. Araie, and G. Tomita Topical administration of iganidipine, a new water-soluble Ca2+ antagonist, increases ipsilateral optic nerve head circulation in rabbits and cynomolgus monkeys Curr. Eye Res. 29 2004 67 73
70. K. Ishii, H. Matsuo, Y. Fukaya, S. Tanaka, H. Sakaki, M. Waki, and M. Araie Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation Invest. Ophthalmol. Vis. Sci. 44 2003 1169 1177
71. M. Kanda, H. Shirahase, K. Kurahashi, K. Wada, S. Nakamura, H. Matsui, and F. Fukata Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries Arzneimittelforschung 45 1995 831 835
72. S. Kazda, and R. Towart Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action Acta Neurochir (Wien) 63 1982 259 265
73. S.P. Kelly, and T.J. Walley Effect of the calcium antagonist nifedipine on intraocular pressure in normal subjects Br. J. Ophthalmol. 72 1988 216 218
74. Y. Kitazawa, H. Shirai, and F.J. Go The effect of Ca2(+) -antagonist on visual field in low-tension glaucoma Graefe's Arch. Clin. Exp. Ophthalmol (Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie) 227 1989 408 412
75. H.J. Koch Altered response characteristics of cat visual neurons after systemic administration of the dihydropyridine calcium antagonist nimodipine Acta Physiol. Pharmacol. Bulg. 23 1998 47 53
76. N. Koseki, M. Araie, A. Tomidokoro, M. Nagahara, T. Hasegawa, Y. Tamaki, and S. Yamamoto A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure Ophthalmology 115 2008 2049 2057
77. N. Koseki, M. Araie, J. Yamagami, S. Shirato, and S. Yamamoto Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure J. Glaucoma 8 1999 117 123
78. L.A. Labiche, and J.C. Grotta Clinical trials for cytoprotection in stroke NeuroRx 1 2004 46 70
79. M.G. Lang, P. Zhu, P. Meyer, G. Noll, I.O. Haefliger, J. Flammer, and T.F. Luscher Amlodipine and benazeprilat differently affect the responses to endothelin-1 and bradykinin in porcine ciliary arteries: effects of a low and high dose combination Curr. Eye Res. 16 1997 208 213
80. M.J. Langman, R.J. Lancashire, K.K. Cheng, and P.M Stewart Systemic hypertension and glaucoma: mechanisms in common and co-occurrence Br. J. Ophthalmol. 89 2005 960 963
81. M. Leist, and P. Nicotera Calcium and neuronal death Rev. Physiol. Biochem. Pharmacol. 132 1998 79 125
82. M.C. Leske, A.M. Connell, S.Y. Wu, L.G. Hyman, and A.P. Schachat Risk factors for open-angle glaucoma. The Barbados eye study Arch. Ophthalmol. 113 1995 918 924
83. M.C. Leske, A. Heijl, L. Hyman, B. Bengtsson, L. Dong, and Z. Yang Predictors of long-term progression in the early manifest glaucoma trial Ophthalmology 114 2007 1965 1972
84. M.C. Leske, S.Y. Wu, A. Hennis, R. Honkanen, and B. Nemesure Risk factors for incident open-angle glaucoma: the Barbados eye studies Ophthalmology 115 2008 85 93
85. P.R. Lichter, D.C. Musch, B.W. Gillespie, K.E. Guire, N.K. Janz, P.A. Wren, and R.P. Mills Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery Ophthalmology 108 2001 1943 1953
86. P. Lipton, and D. Lobner Mechanisms of intracellular calcium accumulation in the CA1 region of rat hippocampus during anoxia in vitro Stroke 21 1990 III60 64
87. C.J. Liu, H.J. Chiou, S.C. Chiang, J.C. Chou, Y.H. Chou, and J.H. Liu Variations in ocular hemodynamics in patients with early and late glaucoma Acta Ophthalmol. Scand. 77 1999 658 662
88. S. Liu, S.V. Araujo, G.L. Spaeth, L.J. Katz, and M. Smith Lack of effect of calcium channel blockers on open-angle glaucoma J. Glaucoma. 5 1996 187 190
89. A. Luksch, G. Rainer, D. Koyuncu, P. Ehrlich, T. Maca, M.E. Gschwandtner, C. Vass, and L. Schmetterer Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma Br. J. Ophthalmol. 89 2005 21 25
90. A. Maltese, and C. Bucolo Pharmacokinetic profile of topical flunarizine in rabbit eye and plasma J. Ocul. Pharmacol. Ther. 19 2003 171 179
91. D.P. McKernan, M.B. Guerin, C.J. O'Brien, and T.G. Cotter A key role for calpains in retinal ganglion cell death Invest. Ophthalmol. Vis. Sci. 48 2007 5420 5430
92. J. Melena, J. Santafe, and J. Segarra The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits J. Pharmacol. Exp. Ther. 284 1998 278 282
93. J. Melena, D. Stanton, and N.N. Osborne Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels Graefe's Arch. Clin. Exp. Ophthalmol. (Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie) 239 2001 522 530
94. J. Melena, J.P. Wood, and N.N. Osborne Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for l-type Ca2+ channels Eur. J. Pharmacol. 378 1999 317 322
95. P. Meyer, M.G. Lang, J. Flammer, and T.F. Luscher Effects of calcium channel blockers on the response to endothelin-1, bradykinin and sodium nitroprusside in porcine ciliary arteries Exp. Eye Res. 60 1995 505 510
96. F. Michalk, G. Michelson, J. Harazny, U. Werner, W.G. Daniel, and D. Werner Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma J. Glaucoma 13 2004 158 162
97. G. Michelson, S. Warntges, S. Leidig, J. Lotsch, and G. Geisslinger Nimodipine plasma concentration and retinal blood flow in healthy subjects Invest. Ophthalmol. Vis. Sci. 47 2006 3479 3486
98. T. Mito, N.A. Delamere, and M. Coca-Prados Calcium-dependent regulation of cation transport in cultured human nonpigmented ciliary epithelial cells Am. J. Physiol. 264 1993 C519 526
99. K. Mizuno, T. Koide, S. Shimada, J. Mori, K. Sawanobori, and M. Araie Route of penetration of topically instilled nipradilol into the ipsilateral posterior retina Invest. Ophthalmol. Vis. Sci. 50 2009 2839 2847
100. K. Mizuno, T. Koide, M. Yoshimura, and M. Araie Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action Invest. Ophthalmol. Vis. Sci. 42 2001 688 694
101. A.A. Mohamed, O. Gotoh, D.I. Graham, K.A. Osborne, J. McCulloch, A.D. Mendelow, G.M. Teasdale, and A.M. Harper Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion Ann. Neurol. 18 1985 705 711
102. M.L. Monica, R.J. Hesse, and F.H. Messerli The effect of a calcium-channel blocking agent on intraocular pressure Am. J. Ophthalmol. 96 1983 814
103. D.C. Musch, B.W. Gillespie, P.R. Lichter, L.M. Niziol, and N.K. Janz Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors Ophthalmology 116 2009 200 207
104. R.P. Muskens, S. de Voogd, R.C. Wolfs, J.C. Witteman, A. Hofman, P.T. de Jong, B.H. Stricker, and N.M. Jansonius Systemic antihypertensive medication and incident open-angle glaucoma Ophthalmology 114 2007 2221 2226
105. T. Nagata, S. Ueno, H. Morita, T. Kubota, Y. Toyohira, M. Tsutsui, A. Tawara, and N. Yanagihara Direct inhibition of N-methyl-d-aspartate (NMDA)-receptor function by antiglaucomatous beta-antagonists J. Pharmacol. Sci. 106 2008 423 434
106. E. Nakajima, L.L. David, C. Bystrom, T.R. Shearer, and M. Azuma Calpain-specific proteolysis in primate retina: contribution of calpains in cell death Invest. Ophthalmol. Vis. Sci. 47 2006 5469 5475
107. P.A. Netland, N. Chaturvedi, and E.B. Dreyer Calcium channel blockers in the management of low-tension and open-angle glaucoma Am. J. Ophthalmol. 115 1993 608 613
108. P.A. Netland, G.T. Feke, S. Konno, D.G. Goger, and N. Fujio Optic nerve head circulation after topical calcium channel blocker J. Glaucoma 5 1996 200 206
109. P.A. Netland, C.L. Grosskreutz, G.T. Feke, and L.J. Hart Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker Am. J. Ophthalmol. 119 1995 694 700
110. P. Nicotera, M. Ankarcrona, E. Bonfoco, S. Orrenius, and S.A. Lipton Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress Adv. Neurol. 72 1997 95 101
111. P. Nicotera, and S. Orrenius The role of calcium in apoptosis Cell Calcium 23 1998 173 180
112. P.J. Nielsen, and N.C. Nyborg Calcium antagonist-induced relaxation of the prostaglandin-F2 alpha response of isolated calf retinal resistance arteries Exp. Eye Res. 48 1989 329 335
113. M. Nirei Blood flow changes in the optic nerve head of albino rabbits following intravenous administration of brovincamine fumarate, an improver of cerebral circulation and metabolism J. Jpn. Ophthalmol. Soc. 100 1996 118 125
114. Y. Niwa, T. Yamamoto, A. Harris, L. Kagemann, H. Kawakami, and Y. Kitazawa Relationship between the effect of carbon dioxide inhalation or nilvadipine on orbital blood flow in normal-tension glaucoma J. Glaucoma 9 2000 262 267
115. N.C. Nyborg, D. Prieto, S. Benedito, and P.J. Nielsen Endothelin-1-induced contraction of bovine retinal small arteries is reversible and abolished by nitrendipine Invest. Ophthalmol. Vis. Sci. 32 1991 27 31
116. M. Ohtsuka, T. Ono, J. Hiroi, K. Esumi, H. Kikuchi, and S. Kumada Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists J. Cardiovasc. Pharmacol. 5 1983 1074 1082
117. M. Ohtsuka, S. Sakai, S. Miura, M. Kurosaki, Y. Koibuchi, T. Ono, and F. Shibayama Effects of nilvadipine, a new calcium entry blocker, on systemic blood pressure, cardiac hypertrophy and venous distensibility in spontaneously hypertensive rats Arch. Int. Pharmacodyn. Ther. 301 1989 228 245
118. T. Oka, Y. Tamada, E. Nakajima, T.R. Shearer, and M. Azuma Presence of calpain-induced proteolysis in retinal degeneration and dysfunction in a rat model of acute ocular hypertension J. Neurosci. Res. 83 2006 1342 1351
119. N.N. Osborne, R.J. Casson, J.P. Wood, G. Chidlow, M. Graham, and J. Melena Retinal ischemia: mechanisms of damage and potential therapeutic strategies Prog. Retin. Eye Res. 23 2004 91 147
120. N.N. Osborne, L. DeSantis, J.H. Bae, M. Ugarte, J.P. Wood, M.S. Nash, and G. Chidlow Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina Exp. Eye Res. 69 1999 331 342
121. N.N. Osborne, J.P. Wood, G. Chidlow, R. Casson, L. DeSantis, and K.G. Schmidt Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma Brain Res. Bull. 62 2004 525 528
122. N.N. Osborne, J.P. Wood, A. Cupido, J. Melena, and G. Chidlow Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity Invest. Ophthalmol. Vis. Sci. 43 2002 1456 1464
123. F. Paquet-Durand, L. Johnson, and P. Ekstrom Calpain activity in retinal degeneration J. Neurosci. Res. 85 2007 693 702
124. L.J. Payne, T.M. Slagle, L.T. Cheeks, and K. Green Effect of calcium channel blockers on intraocular pressure Ophthalmic Res. 22 1990 337 341
125. J.R. Piltz, S. Bose, and D. Lanchoney The effect of nimodipine, a centrally active calcium antagonist, on visual function and mascular blood flow in patients with normal-tension glaucoma and control subjects J. Glaucoma 7 1998 336 342
126. H.A. Quigley, and A.T. Broman The number of people with glaucoma worldwide in 2010 and 2020 Br. J. Ophthalmol. 90 2006 262 267
127. H.A. Quigley, S.K. West, J. Rodriguez, B. Munoz, R. Klein, and R. Snyder The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER Arch. Ophthalmol. 119 2001 1819 1826
128. G. Rainer, B. Kiss, S. Dallinger, O. Findl, M. Georgopoulos, C. Vass, R. Menapace, K. Polak, H.G. Eichler, M. Wolzt, and L. Schmetterer A double masked placebo controlled study on the effect of nifedipine on optic nerve blood flow and visual field function in patients with open angle glaucoma Br. J. Clin. Pharmacol. 52 2001 210 212
129. A.R. Rudnicka, S. Mt-Isa, C.G. Owen, D.G. Cook, and D. Ashby Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis Invest. Ophthalmol. Vis. Sci. 47 2006 4254 4261
130. S. Saito, M. Ohashi, A. Naito, Y. Fukaya, Y. Suzuki, and M. Araie Neuroprotective effect of the novel Na+/Ca2+ channel blocker NS-7 on rat retinal ganglion cells Jpn. J. Ophthalmol. 49 2005 371 376
131. J. Santafe, M.J. Martinez de Ibarreta, J. Segarra, and J. Melena A long-lasting hypotensive effect of topical diltiazem on the intraocular pressure in conscious rabbits Naunyn Schmiedebergs Arch. Pharmacol. 355 1997 645 650
132. J. Santafe, M.J. Martinez de Ibarreta, J. Segarra, and J. Melena The effect of topical diltiazem on ocular hypertension induced by water loading in rabbits Gen. Pharmacol. 32 1999 201 205
133. J. Santafe, M.J. Martinez de Ibarreta, J. Segarra, J. Melena, and M. Garrido A complex interaction between topical verapamil and timolol on intraocular pressure in conscious rabbits Naunyn Schmiedebergs Arch. Pharmacol. 354 1996 198 204
134. M. Satilmis, S. Orgul, B. Doubler, and J. Flammer Rate of progression of glaucoma correlates with retrobulbar circulation and intraocular pressure Am. J. Ophthalmol. 135 2003 664 669
135. R. Sattler, and M. Tymianski Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death Mol. Neurobiol. 24 2001 107 129
136. A. Sawada, Y. Kitazawa, T. Yamamoto, I. Okabe, and K. Ichien Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma Ophthalmology 103 1996 283 288
137. K.G. Schmidt, T.W. Mittag, S. Pavlovic, and V. Hessemer Influence of physical exercise and nifedipine on ocular pulse amplitude Graefe's Arch. Clin. Exp. Ophthalmol. (Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie) 234 1996 527 532
138. J. Schumann, S. Orgul, K. Gugleta, B. Dubler, and J. Flammer Interocular difference in progression of glaucoma correlates with interocular differences in retrobulbar circulation Am. J. Ophthalmol. 129 2000 728 733
139. A. Schurr, and B.M. Rigor The mechanism of cerebral hypoxic-ischemic damage Hippocampus 2 1992 221 228
140. A. Scriabine, T. Schuurman, and J. Traber Pharmacological basis for the use of nimodipine in central nervous system disorders FASEB J. 3 1989 1799 1806
141. A. Scriabine, and W. van den Kerckhoff Pharmacology of nimodipine. A review Ann. N. Y. Acad. Sci. 522 1988 698 706
142. J. Segarra, J. Santafe, M. Garrido, and M.J. Martinez de Ibarreta The topical application of verapamil and nifedipine lowers intraocular pressure in conscious rabbits Gen. Pharmacol. 24 1993 1163 1171
143. M. Setoguchi, Y. Ohya, I. Abe, and M. Fujishima Inhibitory action of betaxolol, a beta 1-selective adrenoceptor antagonist, on voltage-dependent calcium channels in guinea-pig artery and vein Br. J. Pharmacol. 115 1995 198 202
144. T. Shigeeda, A. Tomidokoro, M. Araie, N. Koseki, and S. Yamamoto Long-term follow-up of visual field progression after trabeculectomy in progressive normal-tension glaucoma Ophthalmology 109 2002 766 770
145. H. Shimamoto, and Y. Shimamoto Nilvadipine increases cerebral blood flow in elderly hypertensives: comparison with nifedipine J. Hum. Hypertens. 9 1995 271 279
146. M. Shimazawa, T. Sugiyama, I. Azuma, M. Araie, Y. Iwakura, M. Watari, T. Sakai, and H. Hara Effect of lomerizine, a new Ca(2+)channel blocker, on the microcirculation in the optic nerve head in conscious rabbits: a study using a laser speckle technique Exp. Eye Res. 69 1999 185 193
147. S.W. Siegner, P.A. Netland, A. Schroeder, and K.A. Erickson Effect of calcium channel blockers alone and in combination with antiglaucoma medications on intraocular pressure in the primate eye J. Glaucoma 9 2000 334 339
148. B.K. Siesjo, and F. Bengtsson Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis J. Cereb. Blood Flow Metab. 9 1989 127 140
149. K. Steinhausen, F. Stumpff, O. Strauss, H. Thieme, and M. Wiederholt Influence of muscarinic agonists and tyrosine kinase inhibitors on l-type Ca(2+) channels in human and bovine trabecular meshwork cells Exp. Eye Res. 70 2000 285 293
150. A.K. Stout, H.M. Raphael, B.I. Kanterewicz, E. Klann, and I.J. Reynolds Glutamate-induced neuron death requires mitochondrial calcium uptake Nat. Neurosci. 1 1998 366 373
151. K. Strenn, B. Matulla, M. Wolzt, O. Findl, M.C. Bekes, U. Lamsfuss, U. Graselli, G. Rainer, R. Menapace, H.G. Eichler, and L. Schmetterer Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans Clin. Pharmacol. Ther. 63 1998 54 63
152. H. Sugawara, K. Tobise, and K. Kikuchi Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation Hypertens. Res. 19 1996 223 228
153. K. Takahashi, T.T. Lam, D.P. Edward, E.R. Buchi, and M.O. Tso Protective effects of flunarizine on ischemic injury in the rat retina Arch. Ophthalmol. 110 1992 862 870
154. Y. Takano, H. Ohguro, M. Dezawa, H. Ishikawa, H. Yamazaki, I. Ohguro, K. Mamiya, T. Metoki, F. Ishikawa, and M. Nakazawa Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse Biochem. Biophys. Res. Commun. 313 2004 1015 1022
155. J. Takayama, A. Tomidokoro, K. Ishii, Y. Tamaki, Y. Fukaya, T. Hosokawa, and M. Araie Time course of the change in optic nerve head circulation after an acute increase in intraocular pressure Invest. Ophthalmol. Vis. Sci. 44 2003 3977 3985
156. Y. Tamaki, M. Araie, Y. Fukaya, M. Nagahara, A. Imamura, M. Honda, R. Obata, and K. Tomita Effects of lomerizine, a calcium channel antagonist, on retinal and optic nerve head circulation in rabbits and humans Invest. Ophthalmol. Vis. Sci. 44 2003 4864 4871
157. A. Tawara, T. Tanaka, K. Tsujioka, Y. Sudo, and Y. Ohnishi Effects of brovincamine fumarate on choroidal blood volume in rabbits J. Jpn. Ophthalmol. Soc. 102 1998 654 661
158. The AGIS Investigators The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration Am J Ophthalmol 130 2000 429 440
159. The American Nimodipine Study Group Clinical trial of nimodipine in acute ischemic stroke Stroke 23 1992 3 8
160. H. Thieme, K. Steinhausen, A. Ottlecz, G.N. Lambrou, O. Strauss, M. Wiederholt, and R. Rosenthal Effects of unoprostone and endothelin 1 on l-type channel currents in human trabecular meshwork cells Ophthalmic. Res. 37 2005 293 300
161. J.M. Tielsch, J. Katz, A. Sommer, H.A. Quigley, and J.C. Javitt Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment Arch. Ophthalmol. 113 1995 216 221
162. K. Tomita, M. Araie, Y. Tamaki, M. Nagahara, and T. Sugiyama Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects Invest. Ophthalmol. Vis. Sci. 40 1999 1144 1151
163. N. Toriu, A. Akaike, H. Yasuyoshi, S. Zhang, S. Kashii, Y. Honda, M. Shimazawa, and H. Hara Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina Exp. Eye Res. 70 2000 475 484
164. N. Toriu, M. Sasaoka, M. Shimazawa, T. Sugiyama, and H. Hara Effects of lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1-disturbed circulation in the optic nerve head of rabbits J. Ocul. Pharmacol. Ther. 17 2001 131 149
165. B.F. Trump, and I.K. Berezesky Calcium-mediated cell injury and cell death FASEB J. 9 1995 219 228
166. A. Uemura, and A. Mizota Retinal concentration and protective effect against retinal ischemia of nilvadipine in rats Eur. J. Ophthalmol. 18 2008 87 93
167. 2+ antagonists nifedipine and nimodipine across the blood-brain barrier and their regional distribution in vivo J. Cereb. Blood Flow Metab 5 Suppl. 1 1985 459 460
168. K. Wada, S. Nakamura, S. Morishita, M. Kanda, H. Matsui, F. Fukata, and H. Shirahase Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats Arzneimittelforschung 44 1994 1112 1116
169. A.N. Wadworth, and D. McTavish Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders Drugs Aging 2 1992 262 286
170. M. Waki, T. Sugiyama, N. Watanabe, T. Ogawa, H. Shirahase, and I. Azuma Effect of topically applied iganidipine dihydrochloride, a novel calcium antagonist, on optic nerve head circulation in rabbits Jpn. J. Ophthalmol. 45 2001 76 83
171. R.F. Wang, D.J. Gagliuso, and S.M. Podos Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys J. Glaucoma 17 2008 73 78
172. J.F. Whitfield Calcium signals and cancer Crit. Rev. Oncog. 3 1992 55 90
173. M. Wiederholt, H. Thieme, and F. Stumpff The regulation of trabecular meshwork and ciliary muscle contractility Prog. Retin. Eye Res. 19 2000 271 295
174. R.P. Wilson, W.J. Chang, R.C. Sergott, M.R. Moster, C.M. Schmidt, J.B. Bond, and A. Harris A color Doppler analysis of nifedipine-induced posterior ocular blood flow changes in open-angle glaucoma J. Glaucoma 6 1997 231 236
175. E. Woo Cheon, Y. Hee Kim, Y. Yun Cho, H. Joon Kim, S. Soo Kang, G. Jae Cho, J. Myong Yoo, J. Kyung Song, and W. Sung Choi Betaxolol, a beta1-adrenoceptor antagonist, protects a transient ischemic injury of the retina Exp. Eye Res. 75 2002 591 601
176. J.P. Wood, L. DeSantis, H.M. Chao, and N.N. Osborne Topically applied betaxolol attenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA Exp. Eye Res. 72 2001 79 86
177. J.P. Wood, K.G. Schmidt, J. Melena, G. Chidlow, H. Allmeier, and N.N. Osborne The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol Exp. Eye Res. 76 2003 505 516
178. K.Y. Wu, H.Z. Wang, and S.J. Hong Inhibition of endothelin-1 and KCL-induced increase of [CA2+]i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells J. Ocul. Pharmacol. Ther. 20 2004 201 209
179. H. Yamada, Y.N. Chen, M. Aihara, and M. Araie Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia Brain Res. 1071 2006 75 80
180. T. Yamamoto, Y. Niwa, H. Kawakami, and Y. Kitazawa The effect of nilvadipine, a calcium-channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma J. Glaucoma 7 1998 301 305
181. H. Yamazaki, H. Ohguro, T. Maeda, I. Maruyama, Y. Takano, T. Metoki, M. Nakazawa, H. Sawada, and M. Dezawa Preservation of retinal morphology and functions in royal college surgeons rat by nilvadipine, a Ca(2+) antagonist Invest. Ophthalmol. Vis. Sci. 43 2002 919 926
182. Y. Yamazaki, and S.M. Drance The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma Am. J. Ophthalmol. 124 1997 287 295
183. K. Yaoeda, M. Shirakashi, A. Fukushima, S. Funaki, H. Funaki, H. Abe, and N. Tanabe Relationship between optic nerve head microcirculation and visual field loss in glaucoma Acta Ophthalmol. Scand. 81 2003 253 259
184. D.Y. Yu, V.A. Alder, E.N. Su, and S.J. Cringle Relaxation effects of diltiazem, verapamil, and tolazoline on isolated cat ophthalmociliary artery Exp. Eye Res. 55 1992 757 766
185. D.Y. Yu, E.N. Su, S.J. Cringle, V.A. Alder, P.K. Yu, and L. Desantis Effect of betaxolol, timolol and nimodipine on human and pig retinal arterioles Exp. Eye Res. 67 1998 73 81
186. Z.K. Yu, Y.N. Chen, M. Aihara, W. Mao, S. Uchida, and M. Araie Effects of beta-adrenergic receptor antagonists on oxidative stress in purified rat retinal ganglion cells Mol. Vis. 13 2007 833 839
187. J. Zhang, S.M. Wu, and R.L. Gross Effects of beta-adrenergic blockers on glutamate-induced calcium signals in adult mouse retinal ganglion cells Brain Res. 959 2003 111 119